JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, J.
Right arrow Articles by Yamamoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.
Right arrow Articles by Yamamoto, I.

Microvessel Density: Correlation with 18F-FDG Uptake and Prognostic Impact in Lung Adenocarcinomas

JianFei Guo, MD1,2, Kotaro Higashi, MD1, Yoshimichi Ueda, MD3, Manabu Oguchi, MD1, Tsutomu Takegami, MD4, Hirohisa Toga, MD5, Tsutomu Sakuma, MD6, Hajime Yokota, MD1, Shogo Katsuda, MD3, Hisao Tonami, MD1 and Itaru Yamamoto, MD1

1 Department of Radiology, Kanazawa Medical University, Ishikawa, Japan; 2 Department of Radiology, First Affiliated Hospital, China Medical University, Shenyang, People's Republic of China; 3 Department of Pathology, Kanazawa Medical University, Ishikawa, Japan; 4 Department of Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan; 5 Division of Respiratory Disease, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan; and 6 Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa, Japan


Figure 1
View larger version (137K):

[in a new window]
 
FIGURE 1.  (A) Adenocarcinoma with diffuse pattern stained by mAb to CD31. Normal structure was destroyed, and vessels were randomly and diffusely distributed throughout tumor. (B) Adenocarcinoma with alveolar pattern stained by mAb to CD31. Vessels (arrows) in alveolar pattern area were in original distribution; tumor cells filled up alveoli instead of destroying them. (C) Normal alveoli. (D) Consecutive section of same tumor as in B stained by mAb to CD105. Trapped vessels showed negative staining (arrows).

 

Figure 2
View larger version (65K):

[in a new window]
 
FIGURE 2.  Comparison between CD34/{alpha}-SMA double labeling and CD105 in serial sections. (A) Double labeling of CD34 (arrow) and {alpha}-SMA (arrowheads). Left vessel was immature vessel showing staining only with CD34. Right vessel was mature vessel showing staining with both CD34 and {alpha}-SMA. (B) CD105 staining. Only left, immature vessel was positive for CD105 (arrow). Right, mature vessel was negative for CD105 (double arrows).

 

Figure 3
View larger version (10K):

[in a new window]
 
FIGURE 3.  (A) CD31-MVD showed negative correlation with 18F-FDG uptake (P = 0.057). (B) CD105-MVD showed significantly positive correlation with 18F-FDG uptake (P < 0.0001).

 

Figure 4
View larger version (35K):

[in a new window]
 
FIGURE 4.  Kaplan–Meier survival curves based on MVDs in lung adenocarcinomas. Patients with low CD31-MVD had worst disease-free and overall survival probabilities (A and C), whereas patients with low CD105-MVD had best disease-free and overall survival probabilities (B and D).

 

Figure 5
View larger version (127K):

[in a new window]
 
FIGURE 5.  Moderately differentiated adenocarcinoma (2.9 cm) with recurrence in 23 mo. (A) CT scan shows nodule in left lung. (B) 18F-FDG PET shows intense uptake of 18F-FDG in tumor (SUV = 5.76). (C) CD31 immunohistochemical analysis shows high MVD. (D) CD105 immunohistochemical analysis also shows high MVD.

 

Figure 6
View larger version (139K):

[in a new window]
 
FIGURE 6.  BAC (2.0 cm) without recurrence in 50 mo. (A) CT scan shows nodule in right lung. (B) 18F-FDG PET shows modest uptake of 18F-FDG in tumor (SUV = 1.32). (C) CD31 immunohistochemical analysis shows moderate MVD. (D) CD105 immunohistochemical analysis shows low MVD.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.